UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy

International journal of molecular sciences, 2023-12, Vol.25 (1), p.43

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

PloS one, 2016-12, Vol.11 (12), p.e0167906

2016

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (3), p.752-758

2009

Link zum Volltext

Verfügbarkeit prüfen

Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology

BMJ open quality, 2021-03, Vol.10 (1), p.e000934

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study

Journal of clinical oncology, 2021-07, Vol.39 (21), p.JCO2003579-2338

2021

Link zum Volltext

Verfügbarkeit prüfen

Real world implementation of patient report outcomes: Sustainability constraints and impact on patients health outcomes

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.291-291

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma

Journal of neuro-oncology, 2008-10, Vol.90 (1), p.63-76

2008

Link zum Volltext

Verfügbarkeit prüfen

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy

Neurosurgery, 2000-02, Vol.46 (2), p.306-317

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4325: A Phase II exploratory study to identify biomarkers prognostic of clinical response to regorafenib in patients with metastatic colorectal cancer who have failed first-line therapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4325-4325

2020

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life for pembrolizumab (pembro) plus ipilimumab (ipi) versus pembro plus placebo in patients with metastatic NSCLC with PD-L1 tumor proportion score ≥ 50%: KEYNOTE-598

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9038-9038

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT098: Phase 1 first-in-human study of anti-clusterin antibody AB-16B5 in patients with advanced solid malignancies

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT098-CT098

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated non-squamous non-small cell lung cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9052-9052

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of napabucasin with weekly paclitaxel in previously treated metastatic breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1084-1084

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term use of antihypertensive drugs and risk of cancer

Pharmacoepidemiology and drug safety, 2008-11, Vol.17 (11), p.1039-1049

2008

Link zum Volltext

Verfügbarkeit prüfen

Biopsy-driven study to identify biomarkers predictive of clinical response to second-line regorafenib in patients with metastatic colorectal cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS3656-TPS3656

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated platinum resistant ovarian cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5548-5548

2017

Link zum Volltext

Verfügbarkeit prüfen

A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1094-1094

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in advanced non-small cell lung cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9093-9093

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.196-196

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in platinum-resistant ovarian cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5578-5578

2016

Link zum Volltext

Verfügbarkeit prüfen

Eleven years disease-free: role of chemotherapy in metastatic BRCA2 -related breast cancer

Nature reviews. Clinical oncology, 2009-08, Vol.6 (8), p.488-492

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of sorafenib (S) and vinorelbine (V) in metastatic breast cancer (mBC) with pharmacokinetics (PK) analysis

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1099-1099

2012

Link zum Volltext

Verfügbarkeit prüfen

A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2542-2542

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2706: Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2706-2706

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Female
(19)
Male
(18)
Adult
(17)
Chemotherapy
(17)
Middle Aged
(17)
Oncology
(17)
Aged
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Antineoplastic Agents
(11)
Pharmacology. Drug Treatments
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Brain Neoplasms - Drug Therapy
(6)
Lung Neoplasms - Drug Therapy
(6)
Clinical Neurology
(5)
Lung Neoplasms - Pathology
(5)
Neurosciences & Neurology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution

Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology

Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study

Real world implementation of patient report outcomes: Sustainability constraints and impact on patients health outcomes

Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy

Abstract 4325: A Phase II exploratory study to identify biomarkers prognostic of clinical response to regorafenib in patients with metastatic colorectal cancer who have failed first-line therapy

Health-related quality of life for pembrolizumab (pembro) plus ipilimumab (ipi) versus pembro plus placebo in patients with metastatic NSCLC with PD-L1 tumor proportion score ≥ 50%: KEYNOTE-598

Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network

Abstract CT098: Phase 1 first-in-human study of anti-clusterin antibody AB-16B5 in patients with advanced solid malignancies

A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated non-squamous non-small cell lung cancer

A phase 2 study of napabucasin with weekly paclitaxel in previously treated metastatic breast cancer

Long-term use of antihypertensive drugs and risk of cancer

Biopsy-driven study to identify biomarkers predictive of clinical response to second-line regorafenib in patients with metastatic colorectal cancer

A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated platinum resistant ovarian cancer

A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer

A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in advanced non-small cell lung cancer

A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer

A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in platinum-resistant ovarian cancer

Eleven years disease-free: role of chemotherapy in metastatic BRCA2 -related breast cancer

Phase II trial of sorafenib (S) and vinorelbine (V) in metastatic breast cancer (mBC) with pharmacokinetics (PK) analysis

A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies

Abstract 2706: Phase 2 study with pharmacokinetics (PK) analysis of sorafenib and vinorelbine in metastatic breast cancer

Suchergebnisse filtern